phase readout
saveNCT02522611: Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain
NOT_YET_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: PHASE1. Conditions: Intractable Pain, Palliative Care
view source ↗
comments(0)
5-min edit window · permanent after that